 |
| |
| Sep-27-19 | Downgrade |
JP Morgan |
Neutral → Underweight |
$23 → $21 |
|
| Jan-05-18 | Initiated |
BTIG Research |
Buy |
$24 |
|
| Jan-18-17 | Initiated |
Deutsche Bank |
Sell |
$18 |
|
| Oct-12-16 | Initiated |
Avondale |
Mkt Outperform |
$27 |
|
| Aug-18-16 | Upgrade |
JP Morgan |
Underweight → Neutral |
|
|
| Aug-04-15 | Upgrade |
Wedbush |
Neutral → Outperform |
|
|
| Nov-05-13 | Reiterated |
UBS |
Neutral |
$24 → $21.50 |
|
| Jul-30-13 | Downgrade |
UBS |
Buy → Neutral |
$22 → $24 |
|
| Aug-23-12 | Upgrade |
UBS |
Neutral → Buy |
$25 → $22 |
|
| Jul-31-12 | Downgrade |
William Blair |
Outperform → Mkt Perform |
|
|
| May-01-12 | Reiterated |
UBS |
Neutral |
$22 → $25 |
|
| Mar-12-10 | Initiated |
Jefferies & Co |
Buy |
$20 |
|
| Nov-18-09 | Initiated |
William Blair |
Mkt Perform |
|
|
| May-08-09 | Reiterated |
Wedbush Morgan |
Buy |
$26 → $28 |
|
| Apr-14-09 | Initiated |
Piper Jaffray |
Neutral |
|
|
| Dec-12-08 | Downgrade |
Leerink Swann |
Outperform → Mkt Perform |
|
|
| Oct-16-08 | Initiated |
UBS |
Neutral |
|
|
| Oct-10-08 | Initiated |
Cowen & Co |
Neutral |
|
|
| Aug-08-08 | Reiterated |
Canaccord Adams |
Buy |
$24 → $26 |
|
| Jul-15-08 | Reiterated |
Canaccord Adams |
Buy |
$22 → $24 |
|
|
|
| Mar-27-20 04:05PM | Luminex Receives FDA Emergency Use Authorization for NxTAG® CoV Extended Panel to Detect the SARS-CoV-2 Virus that Causes COVID-19 Disease PR Newswire |
| 07:45AM | Is Luminex Corporation's (NASDAQ:LMNX) CEO Paid At A Competitive Rate? Simply Wall St. |
| Mar-17-20 09:02AM | Austin companies at forefront of race to boost coronavirus testing American City Business Journals +9.90% |
| Mar-13-20 07:30AM | Luminex Provides Update on SARS-CoV-2 Validation Testing Efforts PR Newswire +15.29% |
| Mar-11-20 11:30AM | Luminex (LMNX) Up 13.2% Since Last Earnings Report: Can It Continue? Zacks |
| Mar-04-20 09:33AM | Luminex Hits a New 52-Week High: What's Driving the Stock? Zacks |
| 07:30AM | Luminex Provides Updates on Critical Efforts Related to Novel Coronavirus PR Newswire |
| Mar-02-20 08:27AM | Luminex Files for FDA 510(k) Clearance of RSP Flex Assay Zacks +6.46% |
| Mar-01-20 09:00PM | Luminex Corporation Submits VERIGENE(R) II Respiratory Flex Assay for FDA Clearance PR Newswire |
| Feb-24-20 09:00AM | Luminex Corporation Submits VERIGENE® II Respiratory Flex Assay for FDA Clearance PR Newswire |
| Feb-18-20 11:57AM | Luminex Corporation Declares First Quarter Cash Dividend PR Newswire |
| Feb-17-20 05:31AM | Edited Transcript of LMNX earnings conference call or presentation 10-Feb-20 10:00pm GMT Thomson Reuters StreetEvents |
| Feb-13-20 03:10PM | Luminex Corporation to Participate At Upcoming Healthcare Investor Conferences in March 2020 PR Newswire |
| Feb-11-20 09:58AM | Luminex (LMNX) Earnings and Revenues Beat Estimates in Q4 Zacks |
| 07:30AM | Does This Valuation Of Luminex Corporation (NASDAQ:LMNX) Imply Investors Are Overpaying? Simply Wall St. |
| Feb-10-20 04:03PM | Luminex Corporation Reports Fourth Quarter and Full-Year 2019 Results PR Newswire |
| 03:00PM | Luminex Corp. to Host Earnings Call ACCESSWIRE |
| Feb-03-20 12:30PM | Analysts Estimate Luminex (LMNX) to Report a Decline in Earnings: What to Look Out for Zacks |
| Jan-23-20 09:02AM | Luminex Corporation To Release Fourth Quarter and Full-Year 2019 Results After Market Close On February 10, 2020 PR Newswire |
| Jan-13-20 09:44AM | Is Now The Time To Look At Buying Luminex Corporation (NASDAQ:LMNX)? Simply Wall St. |
| Jan-12-20 05:00PM | Luminex Corporation Announces 2019 Highlights and 2020 Guidance; Company to Present at 38th Annual J.P. Morgan Healthcare Conference PR Newswire |
| Jan-02-20 11:23AM | A Trio of High-Quality Stocks GuruFocus.com |
| Dec-13-19 07:03AM | Looking For Steady Income For Your Dividend Portfolio? Is Luminex Corporation (NASDAQ:LMNX) A Good Fit? Simply Wall St. |
| Dec-06-19 12:20PM | Luminex Corporation Declares Fourth Quarter Cash Dividend PR Newswire |
| Dec-04-19 11:30AM | Luminex (LMNX) Up 13.4% Since Last Earnings Report: Can It Continue? Zacks |
| Nov-25-19 09:00AM | Luminex Corporation to Present at the Piper Jaffray 31st Annual Healthcare Conference on December 4, 2019 PR Newswire |
| Nov-14-19 07:19AM | Edited Transcript of LMNX earnings conference call or presentation 4-Nov-19 10:00pm GMT Thomson Reuters StreetEvents |
| Nov-11-19 06:22AM | The Independent Chairman of Luminex Corporation (NASDAQ:LMNX), George Loewenbaum, Just Bought 4.3% More Shares Simply Wall St. +5.04% |
| Nov-05-19 10:41AM | Luminex (LMNX) Reports Q3 Loss, Misses Revenue Estimates Zacks -7.37% |
| Nov-04-19 03:46PM | Luminex Corporation Reports Third Quarter 2019 Results and Submission of VERIGENE II Gastrointestinal Flex Assay to the FDA PR Newswire -8.43% |
| 12:25PM | Does The Luminex Corporation (NASDAQ:LMNX) Share Price Tend To Follow The Market? Simply Wall St. |
| Oct-28-19 12:39PM | Is Luminex Corporation (LMNX) A Good Stock To Buy ? Insider Monkey |
| Oct-25-19 03:43PM | Luminex Corporation To Release Third Quarter 2019 Results After Market Close On November 4, 2019 PR Newswire |
| Oct-04-19 10:03AM | Is Luminex Corporation's (NASDAQ:LMNX) CEO Salary Justified? Simply Wall St. |
| Oct-03-19 10:58AM | Luminex Gets FDA Nod for ARIES MRSA Assay, Boosts Platform Zacks |
| Oct-01-19 09:05AM | Luminex Receives FDA 510(k) Clearance for the ARIES® MRSA Assay PR Newswire |
| Sep-26-19 12:28PM | Luminex Corporation to Present at the Cantor Global Healthcare Conference on October 2, 2019 PR Newswire |
| Sep-04-19 07:26AM | Do Insiders Own Lots Of Shares In Luminex Corporation (NASDAQ:LMNX)? Simply Wall St. |
| Sep-03-19 08:00AM | Luminex Corporation to Present at the Morgan Stanley 17th Annual Global Healthcare Conference PR Newswire |
| Aug-27-19 05:15PM | Luminex Corp (LMNX) President & CEO Nachum Shamir Bought $98,550 of Shares GuruFocus.com |
| Aug-05-19 10:09AM | Edited Transcript of LMNX earnings conference call or presentation 31-Jul-19 8:30pm GMT Thomson Reuters StreetEvents -6.41% |
| Aug-01-19 10:42AM | Luminex (LMNX) Reports Q2 Loss, Beats Revenue Estimates Zacks |
| Jul-31-19 10:24PM | Luminex Corp (DE) (LMNX) Q2 2019 Earnings Call Transcript Motley Fool |
| 04:01PM | Luminex Corporation Reports Second Quarter 2019 Financial Results And Increase In Quarterly Dividend PR Newswire |
| Jul-26-19 12:18PM | If You Had Bought Luminex (NASDAQ:LMNX) Stock A Year Ago, You'd Be Sitting On A 39% Loss, Today Simply Wall St. |
| Jul-24-19 10:32AM | Earnings Preview: Luminex (LMNX) Q2 Earnings Expected to Decline Zacks |
| Jul-11-19 12:34PM | Luminex Corporation Second Quarter Earnings Release Scheduled for July 31, 2019 PR Newswire |
| Jul-03-19 09:41AM | Luminex (LMNX) Presents ARIES MRSA Assay to FDA for Clearance Zacks |
| Jul-01-19 04:31PM | Luminex Submits ARIES MRSA Assay for FDA Clearance PR Newswire |
| Jun-11-19 10:48AM | Is Luminex Corporation's (NASDAQ:LMNX) 1.7% ROE Worse Than Average? Simply Wall St. |
| Jun-05-19 09:30AM | Why Is Luminex (LMNX) Down 3.1% Since Last Earnings Report? Zacks |
| May-31-19 08:31AM | Luminex xMAP Picked by EDP Biotech to Boost Cancer Diagnostics Zacks |
| May-28-19 07:07AM | EDP Biotech to Develop and Market Colorectal Cancer Early Detection Blood Test Using Luminex xMAP® Technology PR Newswire |
| May-27-19 11:25AM | Edited Transcript of LMNX earnings conference call or presentation 6-May-19 8:30pm GMT Thomson Reuters StreetEvents |
| May-21-19 02:38PM | Luminex Corporation Declares Second Quarter Cash Dividend PR Newswire |
| May-14-19 08:00AM | Luminex Corporation to Present at Upcoming Healthcare Investor Conferences PR Newswire |
| May-07-19 06:05AM | Luminex (LMNX) Reports Q1 Loss, Misses Revenue Estimates Zacks -7.96% |
| May-06-19 10:23PM | Luminex Corp (LMNX) Q1 2019 Earnings Call Transcript Motley Fool |
| 05:55PM | Luminex (LMNX) Reports Q1 Loss, Misses Revenue Estimates Zacks |
| 04:49PM | Luminex: 1Q Earnings Snapshot Associated Press |
| 04:01PM | Luminex Corporation Reports First Quarter 2019 Financial Results PR Newswire |
| 09:19AM | Q1 Earnings Outlook For Luminex Benzinga |
| May-02-19 01:56PM | Is Luminex Corporation (LMNX) A Good Stock To Buy? Insider Monkey |
| May-01-19 03:53PM | Should You Be Tempted To Sell Luminex Corporation (NASDAQ:LMNX) Because Of Its P/E Ratio? Simply Wall St. |
| Apr-29-19 10:31AM | Analysts Estimate Luminex (LMNX) to Report a Decline in Earnings: What to Look Out for Zacks |
| Apr-18-19 10:37AM | Luminex Corporation First Quarter Earnings Release Scheduled for May 6, 2019 PR Newswire |
| Mar-28-19 10:42AM | Can Retail Pharmacy USA Lift Walgreens' (WBA) Q2 Earnings? Zacks |
| Mar-26-19 03:27PM | Should Luminex Corporation (NASDAQ:LMNX) Be Part Of Your Income Portfolio? Simply Wall St. |
| Mar-06-19 09:30AM | Luminex (LMNX) Down 2.7% Since Last Earnings Report: Can It Rebound? Zacks |
| Mar-05-19 10:55AM | Luminex Corporation to Present at the Barclays Global Healthcare Conference PR Newswire |
| Feb-26-19 01:48PM | Luminex Corp (LMNX) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com |
| Feb-25-19 08:52AM | In the money Feb. 25: $35M in deals reported, including pair of contracts for military American City Business Journals |
| Feb-21-19 07:16AM | Luminex Hurt By Segmental Sluggishness, Stiff Competition Zacks |
| Feb-20-19 10:46AM | Should You Be Concerned About Luminex Corporations (NASDAQ:LMNX) Historical Volatility? Simply Wall St. |
| Feb-19-19 07:30AM | Market Trends Toward New Normal in salesforce.com, inc, Genpact, Luminex, Rush Enterprises, Kimball International, and Jones Lang LaSalle Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire |
| 01:01AM | MDxHealth (R): MDxHealth Appoints Michael K. McGarrity as CEO GlobeNewswire |
| Feb-08-19 02:52PM | Luminex Corporation Declares First Quarter Cash Dividend PR Newswire |
| Feb-06-19 08:11AM | Luminex (LMNX) Q4 Earnings Miss, 2019 Guidance Lacks Luster Zacks -7.44% |
| Feb-05-19 09:14PM | Edited Transcript of LMNX earnings conference call or presentation 4-Feb-19 9:30pm GMT Thomson Reuters StreetEvents -9.27% |
| Feb-04-19 08:50PM | Luminex Corp (LMNX) Q4 2018 Earnings Conference Call Transcript Motley Fool |
| 06:25PM | Luminex (LMNX) Q4 Earnings Miss Estimates Zacks |
| 05:29PM | Luminex: 4Q Earnings Snapshot Associated Press |
| 04:21PM | Luminex Corporation Reports Fourth Quarter and Full-Year 2018 Financial Results PR Newswire |
| Jan-28-19 10:30AM | Earnings Preview: Luminex (LMNX) Q4 Earnings Expected to Decline Zacks |
| Jan-23-19 02:34PM | Who Has Been Selling Luminex Corporation (NASDAQ:LMNX) Shares? Simply Wall St. |
| Jan-09-19 06:55AM | Luminex's (LMNX) Preliminary Q4 Results Cheer Investors Zacks |
| Jan-07-19 10:03AM | Here's Why Investors Should Hold Luminex (LMNX) Stock Now Zacks |
| 08:00AM | Luminex Announces Preliminary Revenue for the Fourth Quarter and Full Year 2018; Company to Present at 37th Annual J.P. Morgan Healthcare Conference PR Newswire |
| Jan-04-19 08:27AM | LMNX or PACB: Which is a Better MedTech Investment Pick? Zacks |
| Jan-03-19 09:10AM | Luminex Buys MilliporeSigma's Flow Cytometry Unit for $75M Zacks |
| Jan-02-19 09:09AM | Austin's top-performing stocks of 2018 American City Business Journals |
| 08:00AM | Luminex Corporation Completes Acquisition of MilliporeSigma's Flow Cytometry Portfolio PR Newswire |
| Dec-18-18 02:20PM | How Financially Strong Is Luminex Corporation (NASDAQ:LMNX)? Simply Wall St. |
| Dec-11-18 01:46PM | Luminex Corporation Declares Fourth Quarter Cash Dividend PR Newswire |
| 07:30AM | Report: Exploring Fundamental Drivers Behind Sabre, Catalyst Pharmaceuticals, Renewable Energy Group, Luminex, Parker Drilling, and Apollo Endosurgery New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire |
| Dec-05-18 09:30AM | Why Is Luminex (LMNX) Up 12.4% Since Last Earnings Report? Zacks |
| Nov-12-18 12:52PM | Luminex Corporation (NASDAQ:LMNX) Delivered A Weaker ROE Than Its Industry Simply Wall St. |
| Nov-08-18 03:53AM | Edited Transcript of LMNX earnings conference call or presentation 5-Nov-18 9:30pm GMT Thomson Reuters StreetEvents |
| Nov-07-18 11:27AM | Luminex's (LMNX) Q3 Earnings and Revenues Miss Estimates Zacks +6.62% |
| Nov-05-18 10:44PM | Luminex Corporation (LMNX) Q3 Earnings Conference Call Transcript Motley Fool |
|
|
|
|
| Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; ARIES system, a sample to answer real-time PCR platform; ARIES M1 system, a single-module version of the ARIES System; and VERIGENE system, a semi-automated, multiplex, molecular analysis system for the clinical diagnostics market. The company also provides MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; SYNCT data management software solutions; TDAS, an analysis program designed for development and optimization of nucleic acid assays; IDEAS, an image analysis software; and xTAG assays and products to identify the causative agent for respiratory and gastrointestinal infections, as well as IVD kits for cystic fibrosis genotyping and pharmacogenetic assays used to profile genetic mutations related to drug metabolism. In addition, it offers MultiCode assays and products comprising HSV 1&2 assays, and other products to detect infectious agents in clinical samples; ARIES cassettes that are self-contained assay consumables, such as ARIES HSV 1&2 assays, ARIES FLU A/B and RSV assays, ARIES group A strep assays, ARIES bordetella assays, ARIES GBS assay, and ARIES C. difficile assays; and VERIGENE test cartridges, as well as operates as an original equipment manufacturer of custom reagents and instrumentation. The company serves pharmaceutical companies, clinical laboratories, and research and medical institutions. Luminex Corporation was founded in 1995 and is based in Austin, Texas. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| CURRIE HARRISS T | SVP, Finance & CFO | Mar 09 | Option Exercise | 16.55 | 11,217 | 185,641 | 222,913 | Mar 10 05:09 PM | | Myers Randall | SVP, Global Mfg and Quality | Feb 27 | Option Exercise | 16.06 | 10,000 | 160,600 | 35,142 | Feb 28 12:16 PM | | Myers Randall | SVP, Global Mfg and Quality | Feb 27 | Sale | 23.66 | 10,000 | 236,565 | 25,142 | Feb 28 12:16 PM | | Myers Randall | SVP, Global Mfg and Quality | Feb 24 | Option Exercise | 16.06 | 7,702 | 123,694 | 32,844 | Feb 25 05:38 PM | | Myers Randall | SVP, Global Mfg and Quality | Feb 24 | Sale | 23.31 | 7,702 | 179,561 | 25,142 | Feb 25 05:38 PM | | Myers Randall | SVP, Global Mfg and Quality | Feb 20 | Option Exercise | 16.06 | 1,457 | 23,399 | 25,527 | Feb 21 10:35 AM | | Collins Charles J. | SR VP, R&D - US | Feb 20 | Sale | 23.53 | 6,090 | 143,297 | 27,203 | Feb 21 10:42 AM | | Myers Randall | SVP, Global Mfg and Quality | Feb 20 | Sale | 23.90 | 1,457 | 34,822 | 25,142 | Feb 21 10:35 AM | | Myers Randall | SVP, Global Mfg and Quality | Feb 19 | Option Exercise | 16.06 | 15,841 | 254,406 | 39,911 | Feb 21 10:35 AM | | Myers Randall | SVP, Global Mfg and Quality | Feb 19 | Sale | 23.86 | 15,841 | 377,962 | 24,070 | Feb 21 10:35 AM | | LOEWENBAUM G WALTER II | Director | Nov 18 | Buy | 19.80 | 2,955 | 58,509 | 584,551 | Nov 20 11:40 AM | | LOEWENBAUM G WALTER II | Director | Nov 14 | Buy | 19.79 | 2,045 | 40,469 | 581,596 | Nov 15 05:47 PM | | SHAMIR NACHUM | President & CEO | Nov 11 | Buy | 19.30 | 5,000 | 96,482 | 197,534 | Nov 12 12:23 PM | | LOEWENBAUM G WALTER II | Director | Nov 08 | Buy | 18.14 | 36,657 | 664,841 | 579,551 | Nov 08 05:33 PM | | LOEWENBAUM G WALTER II | Director | Nov 07 | Buy | 17.88 | 45,000 | 804,591 | 542,894 | Nov 08 05:33 PM | | SHAMIR NACHUM | President & CEO | Aug 26 | Buy | 19.71 | 5,000 | 98,528 | 192,534 | Aug 27 03:27 PM |
|
|
|
|
|
|
